Periodontal Pocket: Clinical Trials

6 trials for Periodontal Pocket, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown. 6 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 4, Unknown 2
Phase 22Completed 2

Follow Periodontal Pocket: new trials by email Literature Review of Periodontal Pocket trials Research Report on Periodontal Pocket

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice
Amoxicillin, Metronidazole, Placebo - Periodontitis, Periodontal Diseases
Phase 3CompletedRutgers, The State University of New Jersey2362024-04-252026-04-14
Insulin Versus Hyaluronic Acid in Management of Periodontal Defects
Insulin, Hyaluronic acid - Periodontal Diseases, Periodontal Pocket
Phase 3UnknownOctober University for Modern Sciences and Arts302023-01-122023-02-28
Quantitation of Bacteria Associated With Severe Periodontitis by Real -Time PCR Following Application of Diode Laser
medency diode laser, spirazole forte - Periodontal Pocket
Phase 2 / Phase 3CompletedAlexandria University502021-01-012022-07-06
Effect of a Hydrogen-Peroxide and Hyaluronic-Acid Mouthwash (BMG0703) in the Treatment of Periodontitis
Hydrogen Peroxide and Hyaluronic acid filming formulation, Chlorhexidine 0.2%, Placebo - Periodontitis, Bleeding Gum
Phase 3UnknownUniversity of Milan502020-06-012020-06-25
Manuka Honey as an Adjunct to Non-surgical Periodontal Therapy: Clinical Study
Manuka honey - Periodontal Diseases, Periodontal Pocket
Phase 2 / Phase 3CompletedUniversity of Zagreb122017-09-112022-11-30
Efficacy of Amoxicillin-metronidazole Compared to Clindamycin in Patients With Periodontitis and Diabetes
Amoxicillin 500 mg / Metronidazole 250 mg, Clindamycin 300 mg - Periodontitis, Periodontal Pocket
Phase 3CompletedCentro Universitario de Tonalá422014-03-012020-09-16

Narrower conditions

Periodontitis (5)  ·  Periodontal Diseases (3)  ·  Alveolar Bone Loss (1)  ·  Diabetes Mellitus (1)  ·  Gingival Hemorrhage (1)  ·  Insulin Resistance (1)  ·  Periodontal Attachment Loss (1)

Broader conditions

Mouth Diseases (6)  ·  Stomatognathic Diseases (6)  ·  Periodontal Diseases (3)  ·  Glucose Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Bone Diseases (1)  ·  Bone Resorption (1)  ·  Endocrine System Diseases (1)  ·  Gingival Diseases (1)  ·  Hemorrhage (1)  ·  Hyperinsulinism (1)  ·  Musculoskeletal Diseases (1)  ·  Oral Hemorrhage (1)  ·  Pathologic Processes (1)

Interventions

Amoxicillin (2)  ·  Metronidazole (2)  ·  Chlorhexidine (1)  ·  Clindamycin (1)  ·  Hyaluronic Acid (1)  ·  Hydrogen Peroxide (1)  ·  Insulin (1)

Sponsors

Alexandria University (1)  ·  Centro Universitario de Tonalá (1)  ·  October University for Modern Sciences and Arts (1)  ·  Rutgers, The State University of New Jersey (1)  ·  University of Milan (1)  ·  University of Zagreb (1)

Countries

Egypt (2)  ·  Croatia (1)  ·  Italy (1)  ·  United States (1)

Top investigators

Georgios Kotsakis, DDS (1)  ·  Giampietro Farronato, Professor (1)  ·  Gianguido Cossellu, Fellow (1)

Results publications

PMID 38395824, PMID 42474735

NIH funding

4UH3DE031129-02 (1)